Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://nanaszqg217205.blogolenta.com/36020601/trelaglutide-exploring-a-new-option-for-chronic-diseases